Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

Stopped Prematurely terminated due to data inconsistent with the experimental plan and lack of funding

Conditions

• Interstitial Cystitis
• Bladder Pain Syndrome

Interventions

• DRUG: URG101
• DRUG: Placebo
• DRUG: Lidocaine
• DRUG: Heparin

Sponsor

Urigen